• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮腔内冠状动脉成形术(PTCA)后的再狭窄:美国国立心肺血液研究所PTCA注册研究报告

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

作者信息

Holmes D R, Vlietstra R E, Smith H C, Vetrovec G W, Kent K M, Cowley M J, Faxon D P, Gruentzig A R, Kelsey S F, Detre K M

出版信息

Am J Cardiol. 1984 Jun 15;53(12):77C-81C. doi: 10.1016/0002-9149(84)90752-5.

DOI:10.1016/0002-9149(84)90752-5
PMID:6233894
Abstract

The results of follow-up angiography in patients from 27 clinical centers enrolled in the PTCA Registry were analyzed to evaluate restenosis after PTCA. Of 665 patients with successful PTCA, 557 (84%) had follow-up angiography (median follow-up 188 days). Restenosis, defined as an increase of at least 30% from the immediate post-PTCA stenosis to the follow-up stenosis or a loss of at least 50% of the gain achieved at PTCA, was seen in 187 patients (33.6%). The incidence of restenosis in patients who underwent follow-up angiography was highest within the first 5 months after PTCA. Restenosis was found in 56% of patients with definite or probable angina after PTCA and in 14% of patients without angina after PTCA. Twenty-four percent of patients with restenosis did not have either definite or probable angina. Multivariate analysis selected 4 factors associated with increased rate of restenosis: male sex, PTCA of bypass graft stenosis, severity of angina before PTCA and no history of MI before PTCA.

摘要

对参加PTCA注册研究的27个临床中心的患者进行随访血管造影的结果进行分析,以评估PTCA术后再狭窄情况。在665例PTCA成功的患者中,557例(84%)接受了随访血管造影(中位随访时间188天)。187例患者(33.6%)出现再狭窄,定义为从PTCA术后即刻狭窄到随访时狭窄至少增加30%,或丧失PTCA时获得增益的至少50%。接受随访血管造影的患者中,再狭窄发生率在PTCA术后前5个月内最高。PTCA术后有明确或可能心绞痛的患者中56%出现再狭窄,PTCA术后无心绞痛的患者中14%出现再狭窄。24%的再狭窄患者既无明确也无可能心绞痛。多因素分析选出与再狭窄发生率增加相关的4个因素:男性、旁路移植血管狭窄的PTCA、PTCA术前心绞痛严重程度以及PTCA术前无心肌梗死病史。

相似文献

1
Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.经皮腔内冠状动脉成形术(PTCA)后的再狭窄:美国国立心肺血液研究所PTCA注册研究报告
Am J Cardiol. 1984 Jun 15;53(12):77C-81C. doi: 10.1016/0002-9149(84)90752-5.
2
Percutaneous transluminal coronary angioplasty (PTCA) in patients with relative contraindications: results of the National Heart, Lung, and Blood Institute PTCA Registry.
Am J Cardiol. 1984 Jun 15;53(12):82C-88C. doi: 10.1016/0002-9149(84)90753-7.
3
Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience.
Am J Cardiol. 1987 Jul 31;60(3):50B-55B. doi: 10.1016/0002-9149(87)90485-1.
4
Percutaneous transluminal coronary angioplasty (PTCA) in the elderly patient: experience in the National Heart, Lung, and Blood Institute PTCA Registry.老年患者的经皮腔内冠状动脉成形术(PTCA):国立心肺血液研究所PTCA注册研究的经验
Am J Cardiol. 1984 Jun 15;53(12):89C-91C. doi: 10.1016/0002-9149(84)90754-9.
5
Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty.
Am J Cardiol. 1989 Jan 1;63(1):30-4. doi: 10.1016/0002-9149(89)91071-0.
6
Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry.
Circulation. 1993 Mar;87(3):720-7. doi: 10.1161/01.cir.87.3.720.
7
Role of percutaneous transluminal coronary angioplasty in the treatment of unstable angina. Report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Surgery Study Registries.经皮腔内冠状动脉成形术在不稳定型心绞痛治疗中的作用。美国国立心肺血液研究所经皮腔内冠状动脉成形术和冠状动脉手术研究注册中心的报告。
Am J Cardiol. 1984 Jun 15;53(12):131C-135C. doi: 10.1016/0002-9149(84)90766-5.
8
Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
Am Heart J. 2000 Mar;139(3):482-90. doi: 10.1016/s0002-8703(00)90092-9.
9
Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.冠状动脉成形术成功后再狭窄的发生率:一种与时间相关的现象。对342例连续患者在1、2、3和4个月时进行的定量血管造影研究。
Circulation. 1988 Feb;77(2):361-71. doi: 10.1161/01.cir.77.2.361.
10
Role of percutaneous transluminal coronary angioplasty in patients with variant angina and coexistent coronary stenosis refractory to maximal medical therapy.
Clin Cardiol. 1984 Dec;7(12):654-9. doi: 10.1002/clc.4960071206.

引用本文的文献

1
Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.用于冠状动脉疾病的药物涂层球囊:从理论到实践
Curr Treat Options Cardiovasc Med. 2025 Dec;27(1). doi: 10.1007/s11936-025-01084-4. Epub 2025 Mar 19.
2
Treatment and Care of Patients with ST-Segment Elevation Myocardial Infarction-What Challenges Remain after Three Decades of Primary Percutaneous Coronary Intervention?ST段抬高型心肌梗死患者的治疗与护理——在直接经皮冠状动脉介入治疗三十年之后仍存在哪些挑战?
J Clin Med. 2024 May 15;13(10):2923. doi: 10.3390/jcm13102923.
3
Research progress of drug eluting balloon in arterial circulatory system.
药物洗脱球囊在动脉循环系统中的研究进展
Front Cardiovasc Med. 2024 Mar 20;11:1287852. doi: 10.3389/fcvm.2024.1287852. eCollection 2024.
4
Short-term outcomes of drug-coated balloon versus drug-eluting stent for saphenous vein graft lesions in coronary heart disease.药物涂层球囊与药物洗脱支架治疗冠心病大隐静脉桥病变的短期疗效
Front Cardiovasc Med. 2023 Mar 6;10:982880. doi: 10.3389/fcvm.2023.982880. eCollection 2023.
5
The factors influencing the efficiency of drug-coated balloons.影响药物涂层球囊效率的因素。
Front Cardiovasc Med. 2022 Oct 12;9:947776. doi: 10.3389/fcvm.2022.947776. eCollection 2022.
6
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?支架技术的最新进展:它们是否降低心血管事件?
Curr Atheroscler Rep. 2022 Sep;24(9):731-744. doi: 10.1007/s11883-022-01049-z. Epub 2022 Jul 11.
7
Stent visualization methods to guide percutaneous coronary interventions and assess long-term patency.用于指导经皮冠状动脉介入治疗并评估长期通畅性的支架可视化方法。
World J Cardiol. 2021 Sep 26;13(9):416-437. doi: 10.4330/wjc.v13.i9.416.
8
Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease.姜黄素对成年稳定性冠心病患者经皮冠状动脉介入术后炎症反应的影响
Int J Angiol. 2021 Jun;30(2):132-138. doi: 10.1055/s-0040-1720969. Epub 2021 Jan 29.
9
Management of ST Elevation Myocardial Infarction (STEMI) in Different Settings.不同情况下ST段抬高型心肌梗死(STEMI)的管理
Int J Angiol. 2021 Mar;30(1):67-75. doi: 10.1055/s-0041-1723944. Epub 2021 Mar 24.
10
Two decades after coronary radiation therapy: A single center longitudinal clinical study.冠状动脉放射治疗 20 年后:单中心纵向临床研究。
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):E204-E212. doi: 10.1002/ccd.28637. Epub 2019 Dec 2.